Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. - Wikidata - awgldk - TriplyDB

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

http://www.wikidata.org/entity/Q36370290

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Cancer immunotherapy: moving beyond current vaccines Evaluation of in vivo labelled dendritic cell migration in cancer patients Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial Cancer vaccines: the next generation of tools to monitor the anticancer immune response.Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Therapeutic cancer vaccines: past, present, and future Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy Cancer immunotherapy via dendritic cells Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases Dendritic cell-regulatory T-cell interactions control self-directed immunity.Langerhans cells as targets for immunotherapy against skin cancer.Dendritic cell subsets in health and disease.Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.Dendritic cell-based vaccines: barriers and opportunities Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients Aspects of cancer immunotherapy.Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant Recent progress in tumour vaccine development.Novel therapeutic agents under investigation for malignant melanoma.Some interfaces of dendritic cell biology.Clinical application of dendritic cells in cancer vaccination therapy.Targeting dendritic cells for priming cellular immune responses.A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.Dendritic cell therapy for skin cancer.CD4 cells can be more efficient at tumor rejection than CD8 cells Novel dendritic cell-based vaccination in late stage melanoma Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study.RNA transfer and its use in dendritic cell-based immunotherapy.Comparison of the impact of pro- and antiinflammatory immune processes at the two immune-deviated sites, eye and solid tumor and possible consequences for the antitumoral therapy with fever inducers.Dendritic cells as therapeutic vaccines against cancer.Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

P2860

Q21131200-3CCD67F0-5805-46DA-BFE0-8FEDCC7FFC76 Q24548229-C040EAEB-DEB3-43FD-B19F-B945176F6301 Q24799742-1BC86232-6DAB-49E4-9A9F-0D9CF0B7A500 Q24801506-7F39EA39-B812-4C36-ADBB-775CF1967EB9 Q24814450-2BB234D6-1198-43A0-BC64-D3F96B625834 Q26752558-C69921D4-20A9-43D6-8065-40D0F965C9E5 Q26863283-B55BD71B-158E-4A0C-8ED4-375C5039C446 Q27004702-9B59984A-D69C-4000-98E6-32636AF49D32 Q27008423-A16A07FF-B8B0-4FAE-AFDA-C6FA9516D271 Q27021570-46CBAC0B-EEC8-49EA-A687-24A4ECF1F005 Q29615444-C047AF21-C03A-42AF-93BD-5DE2D86E5A74 Q30846001-475A1FB1-7C49-4889-951E-CC01697183E1 Q33421740-A4B00BC0-1A83-43C8-8D6B-A9DF9455525F Q33530527-5675736E-8CE2-4E67-9C27-11CB99D9A856 Q33866394-4955F309-CE59-4CA1-85C2-FFEE26A31D9C Q34004810-8C6B0480-B95B-4985-8616-58F3D87EB796 Q34009436-A3C7D25C-8493-43AA-AD9A-D677985AD2DA Q34582889-CE633F8C-5DE0-4ECA-89F1-880580D63647 Q34597178-AF2A2132-2D1A-4683-982E-D804671C5FE0 Q34661797-5398835D-F36F-4B6C-A15F-EDD581E52C22 Q34959906-7D83951E-DA4D-4E46-B839-20B2CB6B245B Q35021619-80CE101C-782F-43BB-89BE-870B16B6DDFC Q35048340-76051720-F6E2-48D5-A598-941D8955BF82 Q35125382-89C832AC-849C-45B6-BA8E-FAD3866CD024 Q35144001-491E20B7-AC69-4CB5-83A9-3801DB91779F Q35207632-6C4C477B-A11F-4A46-9DE1-8F1746ADAB09 Q35219290-A36BE50B-26B7-475C-9817-6006234FC13E Q35219339-F8944D05-D7BF-4029-A3EA-C376D9814103 Q35549421-5116E2AE-3FA2-4E68-BDE1-137BC03AC9AB Q35621559-A542BA7C-F354-4E2A-897B-E933E30A574E Q35765914-2D2F1975-A7C2-47A8-B4C0-D39E6BFDE32E Q35793849-787011BA-F778-46F6-A9E3-78D71E82ED35 Q35812979-C743EF12-7881-43E4-B9EC-E7B4C9307976 Q35839925-602EBE92-3796-41A8-B9BB-75C60D5079E8 Q35886439-C7EE4935-9FAE-4F4D-B74A-E868CBD8C103 Q36038020-E643EDC3-4B35-4957-B803-D6221A1E477A Q36065947-A28D18E8-FD4B-4934-97A3-15E446B27237 Q36072744-5F1EB8B3-D630-4DEC-B282-AA333071559A Q36085614-7414D5A9-3FBF-4D11-94EA-D12DE9BBCEE5 Q36228405-987D23E6-19C0-48D6-BCE6-2B6832CADBE2

P2860

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

http://www.wikidata.org/entity/Q36370290

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@ast

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@en

type

label

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@ast

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@en

prefLabel

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@ast

Rapid induction of tumor-speci ...... ocyte-derived dendritic cells.

@en

P1433

Q36370290-B3315769-54BE-4706-A7C1-EEA0D3C3B079

P1476

Q36370290-16ADF321-ACA3-4744-9260-F3559A4D3273

P2093

Q36370290-026180F1-2BF1-49A1-BA4D-DB6A4A14210E

Q36370290-02AC9744-66B4-47A6-ADDF-A003649330D6

Q36370290-61295664-F0B3-4E20-9128-DF852721F270

Q36370290-6C245343-E255-40D2-8001-8271EB5C1F8C

Q36370290-6DA9700A-DBB9-4BDB-8692-22361ED840E6

Q36370290-8B9FAFA6-5C59-49C4-ABB5-1B4A78F12940

Q36370290-8FAE3A6E-A263-4AC7-B44A-86D00BB026BC

Q36370290-9F5E846B-67FF-447B-BC5A-B3BAB7B9F36E

Q36370290-ABF7155B-3FF9-4D1B-8860-E9785FCC052C

Q36370290-EED58679-80BC-4C25-935B-3D08848C61BA

P2860

Q36370290-00FA417A-BF4A-4CE1-983F-816BE863DBE7

Q36370290-09272C9B-3561-42C9-A648-26114C835B1C

Q36370290-1671258D-4466-483B-9B58-73E85813F89C

Q36370290-1FA803EE-43A8-4AAB-A548-1AF36A83ABA0

Q36370290-2B15897B-91B8-4585-916C-32F3805F003F

Q36370290-312EC05A-B01B-4111-8805-48097E45BD42

Q36370290-33F3A903-2CCE-4697-BA61-D1B1A5AB7552

Q36370290-3FD7249C-4C95-4485-BDF5-01842FA2111D

Q36370290-491FDBD9-4EA4-419E-BDCE-8F9696C061C7

Q36370290-5D2EAA78-954F-437D-85E0-CD61D7090096

P304

Q36370290-EEA4923D-90B5-4B40-A5C1-B2458BC60EDA

P31

Q36370290-FAFE1FA6-EFA4-4189-9F38-2E77414D81D3

P356

Q36370290-E8A87C36-F146-4971-A4C7-2E74064EF978

P407

Q36370290-C18C55B1-45B7-4EFA-82DD-F0FF81BF592A

P433

Q36370290-6BAD79AE-8734-40DD-A0FA-38F1C8C4546D

P478

Q36370290-6AAA44C0-63FD-4AC8-B559-5C303E0C1F6D

P50

Q36370290-5EF2DC75-43FA-401F-A1D4-5C5D79E6EB13

P577

Q36370290-7D7D0058-6309-4DFE-9F3B-997CC1D4C1EE

P5875

Q36370290-C14EE384-1FC2-4430-8D7A-94795D82170E

P698

Q36370290-981332B3-CC64-421D-AAA7-3BE5A6F8EDAB

P921

Q36370290-5F745F17-64B2-4EFA-B2C4-77B4178854A8

P932

Q36370290-70A6B1CF-E96A-44D1-B8A5-89C0BF2F5F7D

P356

P1433

Journal of Experimental Medicine

P1476

Rapid induction of tumor-speci ...... nocyte-derived dendritic cells

@en

P2093

Armin Bender

http://www.w3.org/2001/XMLSchema#string

Beatrice Schuler-Thurner

http://www.w3.org/2001/XMLSchema#string

Bernadette Feuerstein

http://www.w3.org/2001/XMLSchema#string

Erwin S Schultz

http://www.w3.org/2001/XMLSchema#string

Georg Weinlich

http://www.w3.org/2001/XMLSchema#string

Gerold Schuler

http://www.w3.org/2001/XMLSchema#string

Peter O Fritsch

http://www.w3.org/2001/XMLSchema#string

Petra Woerl

http://www.w3.org/2001/XMLSchema#string

Susanne Ebner

http://www.w3.org/2001/XMLSchema#string

Thomas G Berger

http://www.w3.org/2001/XMLSchema#string

P2860

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Future directions for allergen immunotherapy.

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity.

Dendritic cells as vectors for therapy.

Vaccines and vaccination.

IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.

Active immunization against cancer with dendritic cells: the near future.

P304

1279-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20012100

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P50

Nikolaus Romani

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11351172

http://www.w3.org/2001/XMLSchema#string

P698

12021308

http://www.w3.org/2001/XMLSchema#string

P921

cryopreservation

P932

2193752

http://www.w3.org/2001/XMLSchema#string